The rapid diagnosis of smear‐negative pulmonary tuberculosis: A cost‐effectiveness analysis
Lists
Only you see this
Abstract
We conclude that the pretest risk of active PTB was a key determinant of test utility; that the AMPLICOR assay was comparable to clinical judgement; that BAL was the least useful test; and that with increasing risks, CT scan and test combinations performed better. Further studies are needed to better define patients with intermediate risk for PTB and to directly compare the cost-effectiveness of more sensitive nucleic acid amplification tests such as the enhanced Gen Probe, CT scan and test combinations/sequences in these patients.
BibTeX
@inproceedings{lim2000rapid,
author = {T. K. Lim and Johnson Cherian and Kim Leng Poh and Tze-Yun Leong},
title = {{The rapid diagnosis of smear‐negative pulmonary tuberculosis: A cost‐effectiveness analysis}},
booktitle = {Respirology},
year = {2000},
doi = {10.1111/j.1440-1843.2000.00284.x},
}Loading related content...